BTI
IART icon

Blue Trust Inc’s Integra LifeSciences IART Stock Holding History

Blue Trust Inc’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.2K Sell
1,397
-13
-0.9% -$143 ﹤0.01% 1771
2025
Q4 		$17.5K Sell
1,410
-593
-30% -$7.88K ﹤0.01% 1726
2025
Q3 		$28.7K Buy
2,003
+594
+42% +$8.14K ﹤0.01% 1573
2025
Q2 		$17.3K Buy
1,409
+14
+1% +$203 ﹤0.01% 1724
2025
Q1 		$30.7K Buy
1,395
+459
+49% +$10.8K ﹤0.01% 1546
2024
Q4 		$21.2K Buy
936
+590
+171% +$12.9K ﹤0.01% 1586
2024
Q3 		$10.1K Sell
346
-540
-61% -$12.5K ﹤0.01% 2188
2024
Q2 		$31.4K Buy
886
+444
+100% +$13.2K ﹤0.01% 1469
2024
Q1 		$15.7K Sell
442
-132
-23% -$5.28K ﹤0.01% 1318
2023
Q4 		$22K Buy
574
+71
+14% +$2.79K ﹤0.01% 1241
2023
Q3 		$21K Buy
503
+230
+84% +$9.68K ﹤0.01% 1157
2023
Q2 		$16K Sell
273
-1,752
-87% -$84.3K ﹤0.01% 1132
2023
Q1 		$113K Buy
2,025
+1,384
+216% +$78K ﹤0.01% 730
2022
Q4 		$27K Buy
641
+347
+118% +$17.7K ﹤0.01% 1178
2022
Q3 		$16K Buy
294
+102
+53% +$5.23K ﹤0.01% 1176
2022
Q2 		$12K Buy
+192
New +$11.5K ﹤0.01% 1140

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Blue Trust Inc's IART Position: Q1 2026 in Review

Blue Trust Inc reduced its Integra LifeSciences (IART) stake by 0.92% in Q1 2026, selling an estimated $143 and leaving 1,397 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1771.

Blue Trust Inc first reported a position in IART in Q2 2022 and has held it in 16 quarters since. The position peaked at $113K in Q1 2023. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Blue Trust Inc held 1,397 shares of Integra LifeSciences worth $13.2K as of Q1 2026.
  • Blue Trust Inc sold 13 Integra LifeSciences shares in Q1 2026, an estimated $143.
  • Integra LifeSciences made up ﹤0.01% of Blue Trust Inc's portfolio in Q1 2026, its #1771 holding.
  • Blue Trust Inc first reported a position in Integra LifeSciences in Q2 2022 and has held it in 16 quarters since.
  • Blue Trust Inc's Integra LifeSciences position peaked at $113K in Q1 2023.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.